Please assess the completion status of the following clinical trial:

Trial Title: Comparison of the Efficacy and Safety of Two Homologous Active Principles for Local Dental Anesthesia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy men and women, criteria assessed during anamnesis~* Age between 18 and 25 years old~* Presence of lower third molars in the mouth with no level of eruption determined by the clinical oral examination~* Weight / height ratio with a coefficient of variation of no more than 15% of the ideal weight, according to the tables of the Metropolitan Life Insurance~* Lower third molars in a mesio-angulated position evidenced by the panoramic radiography taken for the study in the Faculty of Dentistry of the University of Antioquia, and which is in Nolla's stage equal or greater than 6~* Voluntary acceptance to participate in the study by signing the informed consent~Exclusion Criteria:~* Presence of phobias or traumas related to the dental practice and/or with needles~* Presence of clinical problems such as kidney diseases, cardiovascular diseases, known allergies or drug hypersensitivity discovered through the anamnesis of the clinical history prepared for the investigation~* Hi consumption of alcohol or cigarettes~* Presence of problems related to drug dependence~* Being ill for the last two weeks before the study begins~* use of enzyme inhibitors or inducers for four weeks prior to the participation in the study~* Have used any medication or natural product, seven days prior to the first part of the study~* Have donated blood in the last three months~* Have participated in another clinical trial, thirty days prior to the first part of the study~* Be a member of the research group or a relative of the responsible personnel involved in the study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 22 Years
- Healthy Volunteers: t

Study Arms:
- NS Lower right molar (Type: EXPERIMENTAL): IANB Artheek SP Articaine EPINEPHrine Cartridge 4% 1:100000
- SD Lower Left molar (Type: ACTIVE_COMPARATOR): IANB Septanest Articaine EPINEPHrine Cartridge 4% 1:100000
- NS Lower left molar (Type: EXPERIMENTAL): IANB Artheek SP Articaine EPINEPHrine Cartridge 4% 1:100000
- SD Lower right molar (Type: ACTIVE_COMPARATOR): IANB Septanest Articaine EPINEPHrine Cartridge 4% 1:100000

Based on this trial design, predict the completion outcome and termination type (if applicable).